Understanding PAPP-A Clinical Trials in ADPKD

This webinar will provide evidence-based information about the emerging PAPP-A treatment pathway and what it might mean for people living with autosomal dominant polycystic kidney disease (ADPKD).

Through an engaging discussion with ADPKD experts, we’ll explore this promising new treatment strategy and an overview of the three ongoing clinical trials investigating therapies that target the PAPP-A pathway. We’ll also share resources to learn more about clinical trials and how to get involved.